Literature DB >> 27335098

Brain atrophy measurements should be used to guide therapy monitoring in MS - YES.

Robert Zivadinov1, Michael G Dwyer2, Niels Bergsland3.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 27335098     DOI: 10.1177/1352458516649253

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


× No keyword cloud information.
  8 in total

Review 1.  Future Brain and Spinal Cord Volumetric Imaging in the Clinic for Monitoring Treatment Response in MS.

Authors:  Tim Sinnecker; Cristina Granziera; Jens Wuerfel; Regina Schlaeger
Journal:  Curr Treat Options Neurol       Date:  2018-04-20       Impact factor: 3.598

2.  Brain Atrophy Is Associated with Disability Progression in Patients with MS followed in a Clinical Routine.

Authors:  E Ghione; N Bergsland; M G Dwyer; J Hagemeier; D Jakimovski; I Paunkoski; D P Ramasamy; D Silva; E Carl; D Hojnacki; C Kolb; B Weinstock-Guttman; R Zivadinov
Journal:  AJNR Am J Neuroradiol       Date:  2018-11-22       Impact factor: 3.825

Review 3.  Assessing treatment outcomes in multiple sclerosis trials and in the clinical setting.

Authors:  Carmen Tur; Marcello Moccia; Frederik Barkhof; Jeremy Chataway; Jaume Sastre-Garriga; Alan J Thompson; Olga Ciccarelli
Journal:  Nat Rev Neurol       Date:  2018-01-12       Impact factor: 42.937

4.  Within-patient fluctuation of brain volume estimates from short-term repeated MRI measurements using SIENA/FSL.

Authors:  Roland Opfer; Ann-Christin Ostwaldt; Christine Walker-Egger; Praveena Manogaran; Maria Pia Sormani; Nicola De Stefano; Sven Schippling
Journal:  J Neurol       Date:  2018-03-16       Impact factor: 4.849

5.  An Observational Study to Assess Brain MRI Change and Disease Progression in Multiple Sclerosis Clinical Practice-The MS-MRIUS Study.

Authors:  Robert Zivadinov; Nasreen Khan; Jennie Medin; Pia Christoffersen; Jennifer Price; Jonathan R Korn; Ian Bonzani; Michael G Dwyer; Niels Bergsland; Ellen Carl; Diego Silva; Bianca Weinstock-Guttman
Journal:  J Neuroimaging       Date:  2016-12-05       Impact factor: 2.486

6.  Recommendations of the Polish Medical Society of Radiology and the Polish Society of Neurology for the routinely used magnetic resonance imaging protocol in patients with multiple sclerosis.

Authors:  Marek Sąsiadek; Marcin Hartel; Małgorzata Siger; Katarzyna Katulska; Agata Majos; Ewa Kluczewska; Halina Bartosik-Psujek; Alina Kułakowska; Agnieszka Słowik; Barbara Steinborn; Monika Adamczyk-Sowa; Alicja Kalinowska; Ewa Krzystanek; Robert Bonek; Zbigniew Serafin; Jarosław Sławek; Przemysław Nowacki; Adam Stępień; Sergiusz Jóżwiak; Konrad Rejdak; Krzysztof Selmaj; Jerzy Walecki
Journal:  Pol J Radiol       Date:  2020-05-26

7.  Age-dependent cut-offs for pathological deep gray matter and thalamic volume loss using Jacobian integration.

Authors:  Roland Opfer; Julia Krüger; Lothar Spies; Marco Hamann; Carla A Wicki; Hagen H Kitzler; Carola Gocke; Diego Silva; Sven Schippling
Journal:  Neuroimage Clin       Date:  2020-10-27       Impact factor: 4.881

Review 8.  Detecting neurodegenerative pathology in multiple sclerosis before irreversible brain tissue loss sets in.

Authors:  Jeroen Van Schependom; Kaat Guldolf; Marie Béatrice D'hooghe; Guy Nagels; Miguel D'haeseleer
Journal:  Transl Neurodegener       Date:  2019-12-09       Impact factor: 8.014

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.